Commentary: Testosterone and the metabolic syndrome: cause or consequence?
Open Access
- 24 December 2010
- journal article
- editorial
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 40 (1), 207-209
- https://doi.org/10.1093/ije/dyq254
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Testosterone and type 2 diabetesCurrent Opinion in Endocrinology, Diabetes and Obesity, 2010
- Metformin Reduces Arterial Stiffness and Improves Endothelial Function in Young Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Crossover TrialJournal of Clinical Endocrinology & Metabolism, 2010
- Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetesHuman Molecular Genetics, 2009
- Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and MenNew England Journal of Medicine, 2009
- Treatment with Flutamide, Metformin, and Their Combination Added to a Hypocaloric Diet in Overweight-Obese Women with Polycystic Ovary Syndrome: A Randomized, 12-Month, Placebo-Controlled StudyJournal of Clinical Endocrinology & Metabolism, 2006
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006
- Low Sex Hormone-Binding Globulin, Total Testosterone, and Symptomatic Androgen Deficiency Are Associated with Development of the Metabolic Syndrome in Nonobese MenJournal of Clinical Endocrinology & Metabolism, 2006
- The Metabolic Syndrome and Smoking in Relation to Hypogonadism in Middle-Aged Men: A Prospective Cohort StudyJournal of Clinical Endocrinology & Metabolism, 2005
- Association of Bioavailable, Free, and Total Testosterone With Insulin ResistanceDiabetes Care, 2004
- Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivoJournal of Clinical Endocrinology & Metabolism, 1995